# Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation

> **NCT04815265** · PHASE4 · UNKNOWN · sponsor: **Tianjin Nankai Hospital** · enrollment: 488 (estimated)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04815265
- **Lead sponsor:** Tianjin Nankai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815265, "Remimazolam for Sedation in ICU Patients Undergoing Mechanical Ventilation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04815265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*